BIOBIGGEN
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. It is focusing on the pregnancy and childbirth period, focusing on prenatal screening, supplemented by newborn screening and prenatal diagnosis, and deeply creating the most complete high-throughput prevention and control of genetic diseases and birth defects Sequencing technology series of innovative products, leading enterprises and unicorn enterprises in the subdivision field. The company is headquartered in Beijing Economic and Technological Development Zone, has an overseas research center in Houston, the United States, and an R&D transformation center, GMP production base, and medical testing laboratory in Beijing.
BIOBIGGEN
Industry:
Genetics Health Care Health Diagnostics Medical
Founded:
2020-01-01
Address:
Daxing, Beijing, China
Country:
China
Website Url:
http://www.biobiggen.com
Status:
Active
Contact:
010-87163180
Total Funding:
0
Investors List
Northern Light Venture Capital
Northern Light Venture Capital investment in Venture Round - Biobiggen
More informations about "Biobiggen"
博昊基因
无创产前诊断新技术！解决无创应用的两大难题｜Nature子刊. 张静澜博士、李剑力博士共同作为第一作者发表了《Non-invasive prenatal sequencing for multiple Mendelian monogenic …See details»
Biobiggen - Crunchbase Company Profile & Funding
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. It is focusing on the …See details»
博昊基因-公司简介 - biobiggen.com
博昊基因. BioBiggen . 北京博昊云天科技有限公司（“博昊基因”）是一家由深耕无创产前基因检测市场多年的资深管理团队与全球著名医学遗传学家团队强强联合创办的科技创新企业，并获多 …See details»
Biobiggen - Funding, Financials, Valuation & Investors - Crunchbase
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. Search Crunchbase. Start Free Trial . ... How much funding …See details»
Beijing Biobiggen Technology Co., Ltd. - Drug pipelines, Patents ...
Explore Beijing Biobiggen Technology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 4 literature.See details»
Biobiggen - Crunchbase
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform.See details»
Beijing Biobiggen Technology Co., Ltd. - cnverify.com
Email: [email protected]. Beijing Biobiggen Technology Co., Ltd. Employees: 0-50 ( 72.48% of companies have fewer than 5 employees. ) Registered capital: 1,680,000 RMB ( 6.3% of …See details»
Biobiggen - CoBee Company Profile & Funding Rounds
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. It is focusing on the pregnancy and childbirth period, focusing …See details»
Beijing BioBiggen Technology Co., Ltd., China - Nature
Beijing BioBiggen Technology Co., Ltd., China Time frame: 1 February 2023 - 31 January 2024 Profile ...See details»
Beijing BioBiggen Technology Co., Ltd., China - Nature
Beijing BioBiggen Technology Co., Ltd., China Time frame: 1 May 2023 - 30 April 2024 Profile ...See details»
Beijing BioBiggen Technology Co., Ltd. | Institution outputs - Nature
Beijing BioBiggen Technology Co., Ltd. Time frame: 1 February 2023 - 31 January 2024 View institution profileSee details»
Department of Genetics - Submitter - ClinVar - National Center for ...
Xiaomei Qin, Genetic Counselor Phone: 13241919123 Email: [email protected] Jinglan Zhang, CEO Phone: 18086614690 Email: [email protected]See details»
专业的遗传咨询团队 - biobiggen.com
京icp备20019087号 京公网备-11011502004508See details»
Biobiggen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform.See details»
Ruilin J. - Deputy Director/LP - BioBiggen | 领英 - 领英 (中国)
Clinical NGS · Clinical NGS & Bioinformatics<br>Personlized Medicine, Liquid Biopsy, Leukemia<br>Noninvasive Monogenic Disorder Test, NIPT2, ECS<br>LDT, IVD · 工作经历: …See details»
Comprehensive non-invasive prenatal screening for pregnancies …
Aug 27, 2021 Cell-free DNA extracted from the maternal plasma will be used for an analytically validated comprehensive NIPS test developed by Beijing BioBiggen Technology Co. (Beijing, …See details»
无创产前基因检测 - biobiggen.com
人类正常体细胞含有23对染色体，染色体的增加或缺失会引起染色体异常疾病，这往往发生在胎儿身上。 染色体异常会导致患儿表现出不同程度的智力低下、发育迟缓、以及多器官畸形等症状。See details»
人乳头瘤病毒（HPV）基因检测 - biobiggen.com
什么是人乳头瘤病毒（hpv）？ hpv基因检测的出现，使得可实现目前唯一病因明确可早诊早治的癌症。通过采取女性阴道分泌物的宫颈脱落细胞样本，明确受检者感染何种 hpv、结合临床手 …See details»
好韵添®孕妇外周血胎儿游离DNA单基因病检测 - biobiggen.com
出生缺陷现状 ——多类型防控的需求. 出生缺陷 是指婴儿出生前发生的身体结构或功能异常，是导致婴儿死亡和残疾的重要原因。 全世界大约有3-5%的新生儿被出生缺陷影响 [1] 。 约15-25% …See details»
新生儿遗传性耳聋基因筛查 - biobiggen.com
京icp备20019087号 京公网备-11011502004508See details»